In study by Gellhaar et al., the number of MPO-immunoreactive cells was significantly increased in brain areas affected by neurodegeneration, such as the frontal cortex in AD and the caudate, putamen and midbrain in PD [5]. This evidence concerns the gene MPO and Alzheimer disease.